BR0318114A - Vacinação ou imunização utilizando um regime de iniciação-reforço - Google Patents

Vacinação ou imunização utilizando um regime de iniciação-reforço

Info

Publication number
BR0318114A
BR0318114A BR0318114-6A BR0318114A BR0318114A BR 0318114 A BR0318114 A BR 0318114A BR 0318114 A BR0318114 A BR 0318114A BR 0318114 A BR0318114 A BR 0318114A
Authority
BR
Brazil
Prior art keywords
vaccination
immunization
initiation
booster
kits
Prior art date
Application number
BR0318114-6A
Other languages
English (en)
Other versions
BR0318114B1 (pt
Inventor
Jean-Christophe Franc Audonnet
Laurent Bernard Fischer
Simona Barzu-Le-Roux
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Priority to BRPI0318114-6A priority Critical patent/BR0318114B1/pt
Publication of BR0318114A publication Critical patent/BR0318114A/pt
Publication of BR0318114B1 publication Critical patent/BR0318114B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"VACINAçãO OU IMUNIZAçãO UTILIZANDO UM REGIME DE INICIAçãO-REFORçO". A presente invenção refere-se a processos e composições e kits para a vacinação ou a imunização de um animal, tal como um mamífero, vantajosamente um bovino, que envolve um regime de iniciação-reforço.
BRPI0318114-6A 2003-02-19 2003-02-19 Vacinação ou imunização utilizando um regime de iniciação-reforço BR0318114B1 (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0318114-6A BR0318114B1 (pt) 2003-02-19 2003-02-19 Vacinação ou imunização utilizando um regime de iniciação-reforço

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI0318114-6A BR0318114B1 (pt) 2003-02-19 2003-02-19 Vacinação ou imunização utilizando um regime de iniciação-reforço
PCT/IB2003/001215 WO2004073737A1 (en) 2003-02-19 2003-02-19 Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3

Publications (2)

Publication Number Publication Date
BR0318114A true BR0318114A (pt) 2006-02-07
BR0318114B1 BR0318114B1 (pt) 2014-09-02

Family

ID=32894013

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0318114A BRPI0318114B8 (pt) 2003-02-19 2003-02-19 Vacinação ou imunização utilizando um regime de iniciação-reforço
BRPI0318114-6A BR0318114B1 (pt) 2003-02-19 2003-02-19 Vacinação ou imunização utilizando um regime de iniciação-reforço

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI0318114A BRPI0318114B8 (pt) 2003-02-19 2003-02-19 Vacinação ou imunização utilizando um regime de iniciação-reforço

Country Status (7)

Country Link
EP (1) EP1594537B1 (pt)
AU (1) AU2003215835B2 (pt)
BR (2) BRPI0318114B8 (pt)
CA (1) CA2515978A1 (pt)
MX (1) MXPA05008756A (pt)
NZ (1) NZ541879A (pt)
WO (1) WO2004073737A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR084358A1 (es) 2010-12-27 2013-05-08 Lilly Co Eli Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
CN107779457B (zh) * 2016-08-29 2021-07-23 普莱柯生物工程股份有限公司 疫苗组合物及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1131851A (en) 1965-02-10 1968-10-30 English Electric Co Ltd Electrical protective devices
GB2197321B (en) 1986-09-12 1990-10-03 Genentech Inc Method and vectors for obtaining continuous production of heterologous protein in a eukaryotic host cell line
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
DE3743138A1 (de) 1987-12-18 1989-09-14 Mayr Christian Gmbh & Co Kg Schleifringlose, elektromagnetische ueberlastkupplung
US6291228B1 (en) 1988-08-03 2001-09-18 Vericore Limited Vaccine
AU9128391A (en) * 1990-11-05 1992-05-26 Siba Kumar Samal Bovine respiratory syncytial virus genes
NL9100989A (nl) 1991-06-07 1993-01-04 Stichting Centr Diergeneeskund Bovine herpesvirus type 1 deletiemutanten, daarop gebaseerde vaccins, diagnostische kits voor detectie van bovine herpesvirus type 1.
EP0979101B1 (en) 1996-07-03 2010-10-27 Merial, Inc. Recombinant canine adenovirus 2 (cav2) containing exogenous dna
DE19633684A1 (de) 1996-08-12 1998-02-19 Dirk Dipl Ing Vollenbroich Verfahren zur Inaktivierung von lipidumhüllten Viren
EP0998576B1 (en) 1997-06-23 2007-10-31 The University of Saskatchewan Method for producing a recombinant bovine adenovirus vector
US6451319B1 (en) 1999-04-09 2002-09-17 Schering-Plough Veterinary Corporation Recombinant and mutant adenoviruses
FR2804028B1 (fr) * 2000-01-21 2004-06-04 Merial Sas Vaccins adn ameliores pour animaux de rente

Also Published As

Publication number Publication date
EP1594537B1 (en) 2012-10-24
AU2003215835A1 (en) 2004-09-09
WO2004073737A1 (en) 2004-09-02
MXPA05008756A (es) 2005-10-05
NZ541879A (en) 2009-02-28
AU2003215835B2 (en) 2009-12-10
BR0318114B1 (pt) 2014-09-02
CA2515978A1 (en) 2004-09-02
BRPI0318114B8 (pt) 2022-07-05
EP1594537A1 (en) 2005-11-16

Similar Documents

Publication Publication Date Title
BRPI0715396B8 (pt) método de produção de uma composição para vacina
AR061246A1 (es) Anticuerpos anti- dill4 y metodos que los usan
BRPI0506726B8 (pt) anticorpo monoclonal específico para m-csf e usos deste
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
CR7742A (es) Formulaciones para uso veterinario que contienen productos de origen no animal
CR11017A (es) Anticuerpos anti-robo4 y sus usos
ECSP10010095A (es) 2'-fluoro-2'-desoxitetrahidrouridinas como inhibidores de citidina desaminasa
MA29528B1 (fr) Agents de fixation
CY1116768T1 (el) Συνθεσεις οι οποιες περιεχουν βλαστοκυτταρα θηλυκης γαμετικης σειρας και μεθοδοι χρησης αυτων
ATE438638T1 (de) Sulfoniumsalze als photoinitiatoren für strahlungshärtbare systeme
BRPI0514982A (pt) adjuvante de glicosilceramida para antìgenos de sacarìdeo
BRPI0519496A2 (pt) processo para preparar um composto ou uma composiÇço, e, composiÇço
AR059851A1 (es) Anticuerpos de la egfl7 y metodos de uso
BRPI0810130A8 (pt) Composição de bebida, processo para produzir uma composição de bebida, e, uso de uma composição de bebida
AR059096A1 (es) Anticuerpos anti- efrina -b2 y metodos que usan estos
CO2025006500A2 (es) Composiciones que contienen enzimas que escinden anticuerpos y métodos de uso de las mismas
PY0532063A (es) Generación de plantas con contenido alterado de aceite"
MX2012012479A (es) Metodos, composiciones y accesorios para proporcionar un tratamiento terapeutico.
BR0318114A (pt) Vacinação ou imunização utilizando um regime de iniciação-reforço
BRPI0606639A2 (pt) novo processo para a preparação de indóis substituìdos
PY0532065A (es) "generación de plantas con contenido alterado de aceite"
SV2008002512A (es) Derivados de aminoacidos ref. pc32769a
JOP20210339A1 (ar) أجسام مضادة لـ angpt2
BRPI0913397B8 (pt) método para preparar plasmina
CL2008002003A1 (es) Componente de vacuna anti-pertussis que comprende pertactina (prn) de proteina de membrana celular de bordetella pertussis; procedimiento simplificado para obtener prn con mas de un 90% de pureza.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/09/2014, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REFERENTE A RPI 2278 DE02/09/2014, QUANTO AO NOME DO PROCURADOR.

B25C Requirement related to requested transfer of rights
B25A Requested transfer of rights approved
B25A Requested transfer of rights approved